These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 1808680

  • 1. [Intravenous infusion of L-dopa: current prospective therapies].
    Peppe A, De Angelis D, Tolli VS, Rizzo PA, Scoppetta C.
    Riv Neurol; 1991; 61(5):197-200. PubMed ID: 1808680
    [Abstract] [Full Text] [Related]

  • 2. Nighttime levodopa infusions to treat motor fluctuations in advanced Parkinson's disease: preliminary observations.
    Sage JI, Mark MH.
    Ann Neurol; 1991 Oct; 30(4):616-7. PubMed ID: 1789688
    [Abstract] [Full Text] [Related]

  • 3. Comparison between L-dopa and lisuride intravenous infusions: a clinical study.
    Ruggieri S, Stocchi F, Carta A, Bravi D, Bragoni M, Giorgi L, Agnoli A.
    Mov Disord; 1988 Oct; 3(4):313-9. PubMed ID: 3211176
    [Abstract] [Full Text] [Related]

  • 4. Duodenal levodopa infusion monotherapy vs oral polypharmacy in advanced Parkinson disease.
    Nyholm D, Nilsson Remahl AI, Dizdar N, Constantinescu R, Holmberg B, Jansson R, Aquilonius SM, Askmark H.
    Neurology; 2005 Jan 25; 64(2):216-23. PubMed ID: 15668416
    [Abstract] [Full Text] [Related]

  • 5. Motor fluctuations during continuous levodopa infusions in patients with Parkinson's disease.
    Nutt JG, Carter JH, Lea ES, Woodward WR.
    Mov Disord; 1997 May 25; 12(3):285-92. PubMed ID: 9159720
    [Abstract] [Full Text] [Related]

  • 6. Continuous duodenal infusions of levodopa: plasma concentrations and motor fluctuations in Parkinson's disease.
    Sage JI, Schuh L, Heikkila RE, Duvoisin RC.
    Clin Neuropharmacol; 1988 Feb 25; 11(1):36-44. PubMed ID: 3349496
    [Abstract] [Full Text] [Related]

  • 7. Intermittent vs continuous levodopa administration in patients with advanced Parkinson disease: a clinical and pharmacokinetic study.
    Stocchi F, Vacca L, Ruggieri S, Olanow CW.
    Arch Neurol; 2005 Jun 25; 62(6):905-10. PubMed ID: 15956161
    [Abstract] [Full Text] [Related]

  • 8. Problems in daily motor performances in Parkinson's disease: the continuous dopaminergic stimulation.
    Stocchi F, Ruggieri S, Brughitta G, Agnoli A.
    J Neural Transm Suppl; 1986 Jun 25; 22():209-18. PubMed ID: 3465872
    [Abstract] [Full Text] [Related]

  • 9. Intravenous boluses and continuous infusions of L-dopa methyl ester in fluctuating patients with Parkinson's disease.
    Stocchi F, Ruggieri S, Carta A, Ryatt J, Quinn N, Jenner P, Marsden CD, Agnoli A.
    Mov Disord; 1992 Jun 25; 7(3):249-56. PubMed ID: 1620143
    [Abstract] [Full Text] [Related]

  • 10. Duodenal levodopa infusion for advanced Parkinson's disease: 12-month treatment outcome.
    Antonini A, Isaias IU, Canesi M, Zibetti M, Mancini F, Manfredi L, Dal Fante M, Lopiano L, Pezzoli G.
    Mov Disord; 2007 Jun 15; 22(8):1145-9. PubMed ID: 17661426
    [Abstract] [Full Text] [Related]

  • 11. [Changes in the nigrostriatal dopamine receptor compartment after continuous dopaminergic infusions in Parkinson disease].
    Baronti F, Ruggieri S, Mouradian MM, Bonamartini A, Bocciarelli P, De Pandis MF, Chase TN, Agnoli A.
    Riv Neurol; 1991 Jun 15; 61(6):210-4. PubMed ID: 1813972
    [Abstract] [Full Text] [Related]

  • 12. [Perioperative management of a patient with Parkinson's disease with intravenous infusion of levodopa].
    Mizuno J, Kato S, Watada M, Morita S.
    Masui; 2009 Oct 15; 58(10):1286-9. PubMed ID: 19860235
    [Abstract] [Full Text] [Related]

  • 13. L-dopa treatment and Parkinson's disease.
    Lees AJ.
    Q J Med; 1986 Jun 15; 59(230):535-47. PubMed ID: 3529159
    [Abstract] [Full Text] [Related]

  • 14. Accuracy of acute levodopa challenge for clinical prediction of sustained long-term levodopa response as a major criterion for idiopathic Parkinson's disease diagnosis.
    Merello M, Nouzeilles MI, Arce GP, Leiguarda R.
    Mov Disord; 2002 Jul 15; 17(4):795-8. PubMed ID: 12210878
    [Abstract] [Full Text] [Related]

  • 15. The rationale for continuous dopaminergic stimulation in patients with Parkinson's disease.
    Sage JI, Mark MH.
    Neurology; 1992 Jan 15; 42(1 Suppl 1):23-8; discussion 57-60. PubMed ID: 1347908
    [Abstract] [Full Text] [Related]

  • 16. Motor fluctuations in Parkinson's disease: pathogenetic and therapeutic studies.
    Mouradian MM, Juncos JL, Fabbrini G, Chase TN.
    Ann Neurol; 1987 Oct 15; 22(4):475-9. PubMed ID: 3435068
    [Abstract] [Full Text] [Related]

  • 17. Does tolerance develop to levodopa? Comparison of 2- and 21-H levodopa infusions.
    Nutt JG, Carter JH, Woodward W, Hammerstad JP, Gancher ST.
    Mov Disord; 1993 Apr 15; 8(2):139-43. PubMed ID: 8474479
    [Abstract] [Full Text] [Related]

  • 18. [The L-dopa test in Parkinson's disease].
    Esteguy M, Bonnet AM, Kefalos J, Lhermitte F, Agid Y.
    Rev Neurol (Paris); 1985 Apr 15; 141(5):413-5. PubMed ID: 4048732
    [Abstract] [Full Text] [Related]

  • 19. Response to L-dopa and evolution of motor fluctuations in the early phase of treatment of Parkinson's disease.
    Shif M, Kempster PA.
    Clin Exp Neurol; 1994 Apr 15; 31():38-42. PubMed ID: 7586663
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.